Patents by Inventor Nagaraju Banda
Nagaraju Banda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240342146Abstract: The disclosure relates to chemotherapy treatments and in particular, formulations for antiemetic therapy. Parenteral formulations comprising Palonosetron, NK1 receptor antagonist and a corticosteroid is provided. Also provided is a process of preparing such formulations.Type: ApplicationFiled: June 25, 2024Publication date: October 17, 2024Applicant: LEIUTIS PHARMACEUTICALS LLPInventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA
-
Publication number: 20240307302Abstract: Inflammatory disorders of the lung are induced by COVID-19 disease, asthma, and numerous other disorders. Omega-3 fatty acids (O3FA), particularly docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) or cicosapentaenoic acid (EPA), have known anti-inflammatory and pro-resolving properties. Reduction of lung pathology and inflammation will be accomplished by a mixture incorporating O3FA that is suitable for nebulization using formulas and nebulization apparatus known in the art. The O3FA may be delivered in the form of ethyl esters (EE) or free fatty acid (FEA) oils or non-phosphate-containing glycerolipids or as phospholipids (PL) or as any other form known in the art. The mixture can also be delivered in any of the other forms of inhaled droplet or solids for inhalation known in the art. The patient will inhale for a therapeutically effective period of time to reduce inflammation and improve breathing.Type: ApplicationFiled: August 3, 2022Publication date: September 19, 2024Inventors: Chandrashekhar Kocherlakota, James Thomas Brenna, Sesha Durga Kumar Kothapalli, Nagaraju Banda, Arjun Narala, Srinath Akula
-
Patent number: 12083104Abstract: The disclosure relates to chemotherapy treatments and in particular, formulations for antiemetic therapy. Parenteral formulations comprising Palonosetron, NK1 receptor antagonist and a corticosteroid is provided. Also provided is a process of preparing such formulations.Type: GrantFiled: May 16, 2022Date of Patent: September 10, 2024Assignee: LEIUTIS PHARMACEUTICALS LLPInventors: Chandrashekhar Kocherlakota, Nagaraju Banda
-
Publication number: 20240058272Abstract: The present invention relates to a parenteral lyophilized formulation of duloxetine or a pharmaceutically acceptable salt thereof. Further, this invention relates to duloxetine dissolved in a suitable solvent system comprising one or more buffers, stabilizers, and other pharmaceutically acceptable excipients and subsequently lyophilized. The invention also describes combination formulation of Duloxetine with other active ingredients.Type: ApplicationFiled: November 3, 2023Publication date: February 22, 2024Applicant: LEIUTIS PHARMACEUTICALS LLPInventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA, Santhosh Kumar MANKALA, Suresh PACHAIYAPPAN, Anji Reddy KESHIREDDY
-
Publication number: 20230310465Abstract: The present invention relates to a formulation comprising a nano lipid carrier system comprising an active ingredient, low phase transition solid lipid, PEGylated lipid, surfactants and cosolvents etc, dispersed in water or aqueous medium. The hydrodynamic diameter of the nanocarrier system in aqueous media is less than about 1000 nm. The present invention formulation can be in the form of a liquid (solution, suspension, dispersion), liquid filled hard gelatin capsule, soft gelatin capsule or a liquid concentrate.Type: ApplicationFiled: August 18, 2021Publication date: October 5, 2023Inventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA, Arjun NARALA, Naga Udaya Sankar PULLAGURA, Srinath AKULA
-
Publication number: 20230190639Abstract: Provided are novel parenteral formulations of vasopressin, including of vasopressin, stabilizers, solvent and other pharmaceutically acceptable excipients. Also provided are ready to use and/ ready to dilute formulations for parenteral administration. Further provided is a process for preparing formulations of vasopressin for parenteral administration.Type: ApplicationFiled: February 15, 2023Publication date: June 22, 2023Inventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA
-
Publication number: 20220409544Abstract: The present invention relates to a parenteral lyophilized formulation of duloxetine or a pharmaceutically acceptable salt thereof. Further, this invention relates to duloxetine dissolved in a suitable solvent system comprising one or more buffers, stabilizers, and other pharmaceutically acceptable excipients and subsequently lyophilized. The invention also describes combination formulation of Duloxetine with other active ingredients.Type: ApplicationFiled: November 30, 2020Publication date: December 29, 2022Applicant: LEIUTIS PHARMACEUTICALS LLPInventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA, Santhosh Kumar MANKALA, Suresh PACHAIYAPPAN, Anji Reddy KESHIREDDY
-
Publication number: 20220273630Abstract: The disclosure relates to chemotherapy treatments and in particular, formulations for antiemetic therapy. Parenteral formulations comprising Palonosetron, NK1 receptor antagonist and a corticosteroid is provided. Also provided is a process of preparing such formulations.Type: ApplicationFiled: May 16, 2022Publication date: September 1, 2022Inventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA
-
Patent number: 11364229Abstract: The disclosure relates to chemotherapy treatments and in particular, formulations for antiemetic therapy. Parenteral formulations comprising Palonosetron, NK1 receptor antagonist and a corticosteroid is provided. Also provided is a process of preparing such formulations.Type: GrantFiled: February 20, 2020Date of Patent: June 21, 2022Assignee: LEIUTIS PHARMACEUTICALS PVT, LTDInventors: Chandrashekhar Kocherlakota, Nagaraju Banda
-
Publication number: 20210093553Abstract: Provided are novel parenteral formulations of vasopressin, including of vasopressin, stabilizers, solvent and other pharmaceutically acceptable excipients. Also provided are ready to use and/ready to dilute formulations for parenteral administration. Further provided is a process for preparing formulations of vasopressin for parenteral administration.Type: ApplicationFiled: December 21, 2018Publication date: April 1, 2021Inventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA
-
Publication number: 20210008081Abstract: Liquid formulations of Abiraterone intended for oral administration are provided. Also provided are suspension and emulsion formulations of Abiraterone and processes of preparing such formulations. Further, embodiments of the invention relates to Nanoemulsion formulations of Abiraterone including Abiraterone, oil phase, aqueous phase, one or more emulsifying agents and optionally other pharmaceutical excipients, wherein the concentration of excipients are optimized for better stability.Type: ApplicationFiled: March 28, 2019Publication date: January 14, 2021Inventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA, Santhosh Kumar MANKALA
-
Publication number: 20140142153Abstract: Aspects of the present appliction relate to pharmaceutical formulations comprising bendamustine or its pharmaceutically acceptable salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, polymorphs, and mixtures therof, suitable for phamaceutical use. Aspects further provide methods of producing stable bendamustine compositions.Type: ApplicationFiled: January 25, 2012Publication date: May 22, 2014Applicants: DR. REDDY'S LABORATORIES, INC., DR. REDDY'S LABORATORIES LTD.Inventors: Chandrasekhar Kocherlakota, Tarun Singh, Nagaraju Banda, Nirmal Khati, Sachin Sharma, Prasad Vure, Aparna Mulupuru, Navin Vaya, Amit Anil Charkha
-
Patent number: 8618146Abstract: The present application relates to compositions for parenteral administration of epothilone compounds, such as ixabepilone.Type: GrantFiled: January 3, 2012Date of Patent: December 31, 2013Assignees: Dr. Reddy's Laboratories Limited, Dr. Reddy's Laboratories, Inc.Inventors: Chandrasekhar Kocherlakota, Tarun Singh, Nagaraju Banda, Prasad Vure, Aparna Mulupuru
-
Publication number: 20120277274Abstract: The present application relates to compositions for parenteral administration of epothilone compounds, such as ixabepilone.Type: ApplicationFiled: January 3, 2012Publication date: November 1, 2012Inventors: Chandrasekhar Kocherlakota, Tarun Singh, Nagaraju Banda, Prasad Vure, Aparna Mulupuru
-
Publication number: 20120238596Abstract: Pharmaceutical compositions comprising palonosetron and its pharmaceutically acceptable salts, in the form of a ready-to-use solution or a lyophilized form. Specific embodiments of the invention relate to stable pharmaceutical formulations of palonosetron and its pharmaceutically acceptable salts, wherein the formulation does not comprise a chelating agent or an antioxidant.Type: ApplicationFiled: May 30, 2012Publication date: September 20, 2012Applicants: DR. REDDY'S LABORATORIES, INC., DR. REDDY'S LABORATORIES LIMITEDInventors: Chandrashekhar Kocherlakota, Sreedhar Bandari, Nagaraju Banda, Kranthi Kumar Hinge, Ramachandra Reddy Yeluri
-
Publication number: 20110201631Abstract: Pharmaceutical formulations comprising amorphous pemetrexed or its salts, and processes to prepare the formulations.Type: ApplicationFiled: March 9, 2011Publication date: August 18, 2011Applicants: DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.Inventors: Chandrasekhar Kocherlakota, Raghuveera Hathibelagal Goruva, Krishnam Raju Kovoru, Nagaraju Banda
-
Publication number: 20110178470Abstract: Pharmaceutical compositions comprising bortezomib for oral or parenteral administration. Specific aspects relate to stable, sugar free pharmaceutical compositions of bortezomib, including its pharmaceutically acceptable salts or solvates, in the form of ready-to-use solutions, lyophilized forms, or physical admixtures, and the preparation thereof. Other aspects include processes for preparing compositions and methods of using compositions for treating various types of cancers in mammals.Type: ApplicationFiled: March 31, 2011Publication date: July 21, 2011Applicants: DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.Inventors: Chandrasekhar Kocherlakota, Lavanya Nallamothu, Krishnam Raju Kovoru, Nagaraju Banda, Mittapally Sridhar, Keni Devendra Chandrkanth, Soogareddy Channareddy Shantreddy, Wagh Sanjay Chhagan, Pillai Raviraj Sukumar, Bandari Sreedhar, Hinge Kranthikumar
-
Publication number: 20110042247Abstract: The present invention relates to pharmaceutical formulations comprising azacitidine or its pharmaceutically acceptable salts, including processes for preparing the formulations comprising azacitidine, or salts thereof, and methods of using the formulations for treating various cancer disorders in mammals.Type: ApplicationFiled: June 25, 2010Publication date: February 24, 2011Inventors: Chandrasekhar Kocherlakota, Nagaraju Banda, Tarun Singh, Prahlad Pragallapati, Sachin Sharma, Raghu Nandan Srinivasan
-
Publication number: 20100048607Abstract: Pharmaceutical compositions comprising palonosetron and its pharmaceutically acceptable salts, in the form of a ready-to-use solution or a lyophilized form. Specific embodiments of the invention relate to stable pharmaceutical formulations of palonosetron and its pharmaceutically acceptable salts, wherein the formulation does not comprise a chelating agent or an antioxidant.Type: ApplicationFiled: August 24, 2009Publication date: February 25, 2010Inventors: Chandrashekhar Kocherlakota, Sreedhar Bandari, Nagaraju Banda, Kranthi Kumar Hinge, Ramachandra Reddy Yeluri